FGF19 protects skeletal muscle against obesity‐induced muscle atrophy, metabolic derangement and abnormal irisin levels via the AMPK/SIRT‐1/PGC‐α pathway. The gene discussed is FGF19; the disease is obesity due to melanocortin 4 receptor deficiency.